Tumour necrosis factor mediates bacterial translocation after haemorrhagic shock and endotoxaemia

European Journal of Surgery

Volumn 167, Issue 4, 2001, Pages 299-304

  Goldman, G ^a   Soffer, D ^a   Heller, L ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Bacterial translocation; Endotoxemia; Haemorrhagic shock; Intestinal mucosal barrier; Tumour necrosis factor

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL TRANSLOCATION; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTOXEMIA; HEMORRHAGIC SHOCK; INTESTINE MUCOSA; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ANIMALS; BACTERIAL TRANSLOCATION; ENDOTOXEMIA; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035054230     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241501300091543     Document Type: Article

References (28)

1. Food deprivation increases bacterial translocation after nonlethal haemorrhage in rats
2. Neutrophil activation, tumour necrosis factor, and survival after endotoxic and haemorrhagic shock
3. Passive immunization against cachectin/tumour necrosis factor protects mice from lethal effect of endotoxin
4. A study of the relationship among survival, gut-origin sepsis, and bacterial translocation in a model of systemic inflammation
5. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to haemorrhagic shock
6. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure
7. Haemorrhagic shock in endotoxin-resistant mice: Improved survival unrelated to deficient production of tumour necrosis factor
8. Preliminary study on treatment of septic shock patients with antilipopolysaccharide IgG from blood donors
9. The biologic characteristics of cytokines and their implication in surgical injury
10. TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury
11. Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or haemorrhagic shock
12. Kinetics of endotoxin and tumour necrosis factor appearance in portal and systemic circulation after haemorrhagic shock in rats
13. The gut: A cytokine-generating organ in systemic inflammation
14. Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation
15. Effect of tumour necrosis factor alpha on intrahepatic bile duct epithelial cell of rat liver
16. Effect of anti-tumour necrosis factor alpha on leukocyte adhesion in the liver after haemorrhagic shock: An intravital microscopic study in the rat
17. Combined ibuprofen and monoclonal antibody to tumour necrosis factor-alpha attenuate hemodynamic dysfunction and sepsis-induced acute lung injury
18. Starvation increases the number of coliform bacteria in the caecum and induces bacterial adherence to caecal epithelium in rats
19. Antiserum to endotoxin in haemorrhagic shock
20. Serum tumour necrosis factor-alpha profile in trauma patients
21. Cytokine patterns in patients after major vascular surgery, haemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure
22. Endotoxemia and bacteraemia during haemorrhagic shock. The link between trauma and sepsis
23. Soluble tumour necrosis factor receptors reduce bowel ischemia induced lung permeability and neutrophil sequestration
24. Gut decontamination reduces bowel ischemia induced lung injury in rats
25. Role of tumour necrosis factor-alpha in disease states and inflammation
26. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from haemorrhagic shock and resuscitation in rabbits
27. Inhibitory effects of low-dose polymyxin B on hemorrhage-induced endotoxin/bacterial translocation and cytokine formation in rats
28. Protective effect of Re-LPS antiserum on experimental multiple system organ failure